The growing cases of prostate cancer in the healthcare industry is propelling the market growth.   The global hormone refractory prostate cancer (HRPCA) market is forecast to reach USD 15.64 Billion by 2026, according to a new report by Reports and Data. Hormone refractory prostate cancer (HRPCA), also known as Castrate-Resistant Prostate Cancer (CRPC), is a...